News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Filters
MindMed Successfully Completes Phase 1 Clinical Trial of 18-MC
Mind Medicine (MindMed)
Algernon Pharmaceuticals Issues Compensation Options
Algernon Pharmaceuticals
MindMed Announces Transitions to Management Team
Mind Medicine (MindMed)
Core One Labs Acquires New Path Laboratories
Core One Labs Inc.
Tryp Therapeutics Announces Advancement of Phase 2a Clinical Trial in Binge Eating Disorder
Tryp Therapeutics
Mydecine Signs LOI with Maya to Co-Develop a Novel Prescription Digital Therapeutic Platform Aiming to Further Increase Safety, Efficacy, and Accessibility of Psychedelic-Assisted Treatments
Mydecine Innovations Group
Cybin Provides 2021 Year End Summary
Cybin Inc.
Ixtlan Bioscience Announces the Filing of New Patent for the Psilocybin Treatment of Alzheimer's Disease and Brain Pathologies
Ixtlan Bioscience
Lobe Sciences Announces Publication of PCT Patent Application for Its Combination Therapy for mTBI and PTSD
Lobe Sciences
MindMed Provides Status Update on IND for Phase 2b Trial of LSD for the Treatment of Generalized Anxiety Disorder
Mind Medicine (MindMed)
Optimi Health Receives Dealers License Inspection and Introduces Quality Assurance Department
Optimi Health
Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel
Entheon Biomedical
Cube Psytech Enters Into Supply Agreement With Psygen Labs
Cube Psytech
Psygen Labs
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.